BioCentury
ARTICLE | Financial News

Series B for China's Zai tops $100M

January 9, 2016 2:22 AM UTC

Zai Lab Ltd. (Shanghai, China) said it raised over $100 million in a series B round led by Advantech Capital. New investor OrbiMed joined existing investors Qiming Ventures, Sequoia Capital China and TF Capital.

Zai COO Marietta Wu declined to disclose the round's exact value, but said it was "a few million" over $100 million. ...